Research And Trials
The most aggressive type of ovarian cancer develops from cells that come from the fallopian tubes rather than the ovaries, according to a small study.
Radiotherapy doesn't have to be given from outside the body. Radioactive implants and drinks stay close to tumours to minimise side effects.
A new approach to targeting key cancer-linked proteins, thought to be ‘undruggable’, has been discovered through an alliance between industry and academia
A small new trial in the US has suggested personalised treatment based on tumour features could be effective in patients with rare cancers.
The results of a breast cancer trial we helped fund allowed surgeons to move away from ‘radical’ mastectomies towards kinder, less invasive surgeries.
A greater understanding of the biology of mesothelioma has led to new clinical trials testing immunotherapies and targeted drugs against the disease.
In this week's cancer news there's Brexit plans, viruses being used as treatments, and disagreements over screening for prostate cancer.
Unpublished results from the Cancer Research UK-funded STAMPEDE trial show that two different treatments improve survival in men with advanced prostate cancer.
Unpublished trial results have found that a drug which targets genetic vulnerabilities in tumour cells can delay some advanced ovarian cancers from worsening.